Motley Fool Asset Management LLC Repligen Corp Transaction History

Motley Fool Asset Management LLC

  • $1.85 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $175,339 - $280,037
1,093 New
1,093 $205,000
Q2 2022

Aug 11, 2022
SELL
$140.68 - $188.02 $156,295 - $208,890
-1,111 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$161.19 - $257.96 $174,891 - $279,886
1,085 Added 4173.08%
1,111 $209,000
Q4 2021

Feb 10, 2022
BUY
$247.59 - $304.47 $6,437 - $7,916
26 New
26 $7,000

Others Institutions Holding RGEN

# of Institutions
479
Shares Held
54.9M
Call Options Held
297K
Put Options Held
343K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Motley Fool Asset Management LLC Portfolio

Follow Motley Fool Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email